Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.65.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
LQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KP.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
MF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.29.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.18.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used